483 Roundup: Four Firms Called Out Over Quality, Sanitation Concerns

The FDA issued Form 483s to U.S. and foreign drugmakers, citing violations for sanitation issues, unreliable data and nonconformances, among other observations.
Source: Drug GMP Report